| 14th Apr 2022 7:00 am |
RNS |
Poster on Parsortix system presented at AACR 2022 |
| 1st Apr 2022 7:00 am |
RNS |
Identifying drug targets in cancer metastasis |
| 29th Mar 2022 7:00 am |
RNS |
Rapid information on patient response to therapies |
| 25th Mar 2022 7:00 am |
RNS |
Identifying therapeutic targets in TNBC patients |
| 15th Mar 2022 7:00 am |
RNS |
Update on laboratory accreditation |
| 9th Mar 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 9th Mar 2022 4:36 pm |
RNS |
Price Monitoring Extension |
| 2nd Mar 2022 6:29 pm |
RNS |
Holding(s) in Company |
| 18th Feb 2022 5:13 pm |
RNS |
Issue of Equity |
| 21st Jan 2022 7:00 am |
RNS |
Potential in immunotherapy treatment selection |
| 17th Jan 2022 7:00 am |
RNS |
Concordance of Parsortix with tissue biopsy |
| 13th Jan 2022 7:00 am |
RNS |
Update on lab accreditation and ovarian study |
| 10th Jan 2022 7:00 am |
RNS |
Insight into drug resistance in NSCLC |
| 22nd Dec 2021 6:29 pm |
RNS |
Issue of Equity |
| 1st Dec 2021 6:11 pm |
RNS |
Issue of Equity |
| 1st Dec 2021 7:00 am |
RNS |
Parsortix in RNA analysis of CTCs as tool in NSCLC |
| 26th Nov 2021 5:33 pm |
RNS |
Issue of Equity |
| 17th Nov 2021 10:32 am |
RNS |
Issue of Equity |
| 15th Nov 2021 7:00 am |
RNS |
Issue of LTIP Options and Share Options |
| 15th Nov 2021 7:00 am |
RNS |
Appointment of Chief Medical Officer |
| 12th Nov 2021 5:51 pm |
RNS |
Issue of Equity |
| 12th Nov 2021 7:00 am |
RNS |
Participation at Jefferies healthcare conference |
| 11th Nov 2021 7:00 am |
RNS |
Parsortix system showcased at NCRI Festival |
| 10th Nov 2021 5:40 pm |
RNS |
Issue of Equity |
| 2nd Nov 2021 7:00 am |
RNS |
Change of Adviser |
| 21st Oct 2021 5:25 pm |
RNS |
Issue of Equity |
| 15th Oct 2021 5:45 pm |
RNS |
Issue of Equity |
| 30th Sep 2021 4:02 pm |
RNS |
Issue of Equity |
| 30th Sep 2021 7:00 am |
RNS |
Interim Results |
| 27th Sep 2021 7:00 am |
RNS |
Parsortix demonstrates ability to isolate CTCs |
| 22nd Sep 2021 7:00 am |
RNS |
Study shows use of Parsortix to assess PD-L1 |
| 20th Sep 2021 7:00 am |
RNS |
Parsortix enables gene expression analysis in mPCa |
| 7th Sep 2021 7:00 am |
RNS |
Notice of Interim Results and Webcast |
| 24th Aug 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 9th Aug 2021 7:00 am |
RNS |
Study highlights superior performance of Parsortix |
| 6th Aug 2021 1:17 pm |
RNS |
Issue of Equity |
| 3rd Aug 2021 3:13 pm |
RNS |
Issue of Equity |
| 28th Jul 2021 7:00 am |
RNS |
Contract secured for bespoke assay development |
| 9th Jul 2021 7:00 am |
RNS |
Harvesting CTCs from brain metastasis patients |
| 7th Jul 2021 6:34 pm |
RNS |
Director/PDMR Shareholding |
